Aktiia

Executive Summary

Aktiia is a Swiss digital health company that has developed a clinically validated, cuffless optical blood pressure monitor worn as a bracelet. The device provides automated 24/7 blood pressure monitoring, generating continuous data streams for patients and healthcare providers. Founded in 2018 and based in Neuchâtel, Aktiia aims to transform this unique data into programs and services that improve hypertension management and cardiovascular outcomes. Unlike traditional cuff-based monitors, Aktiia's technology enables passive, frequent measurements without disrupting daily life, potentially leading to better hypertension control and reduced cardiovascular events. The company has already received CE marking and is commercializing in Europe, with ongoing efforts to expand into the U.S. market through FDA clearance. As a private company, Aktiia's valuation and funding details are undisclosed, but its innovative approach to blood pressure monitoring positions it as a key player in the digital health and medical device space. With a strong clinical validation foundation, Aktiia is well-positioned to capture a share of the growing market for remote patient monitoring and chronic disease management.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for U.S. Market Entry70% success
• TBDMajor Health System Partnership for Remote Monitoring Program50% success
• Q4 2026Publication of Landmark Clinical Study Demonstrating Outcomes Improvement65% success